| Primary |
| Metastatic Malignant Melanoma |
38.3% |
| Malignant Melanoma |
37.7% |
| Prophylaxis |
4.0% |
| Hypertension |
3.8% |
| Pain |
3.4% |
| Pyrexia |
1.6% |
| Diabetes Mellitus |
1.1% |
| Epilepsy |
1.1% |
| Atrial Fibrillation |
0.9% |
| Gastritis Prophylaxis |
0.9% |
| Metastases To Central Nervous System |
0.9% |
| Nausea |
0.9% |
| Pancreatitis |
0.9% |
| Colorectal Cancer |
0.7% |
| Dehydration |
0.7% |
| Depression |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Infection |
0.7% |
| Product Used For Unknown Indication |
0.7% |
| Antipsychotic Drug Level Therapeutic |
0.4% |
|
| Pyrexia |
45.3% |
| Ejection Fraction Decreased |
10.9% |
| Vomiting |
7.0% |
| Basal Cell Carcinoma |
4.7% |
| Skin Toxicity |
3.1% |
| Squamous Cell Carcinoma |
3.1% |
| Urinary Tract Infection |
3.1% |
| Alanine Aminotransferase Increased |
2.3% |
| Respiratory Tract Infection |
2.3% |
| Squamous Cell Carcinoma Of Skin |
2.3% |
| Death |
1.6% |
| Dehydration |
1.6% |
| Diarrhoea |
1.6% |
| Febrile Neutropenia |
1.6% |
| Influenza Like Illness |
1.6% |
| Liver Function Test Abnormal |
1.6% |
| Lower Respiratory Tract Infection |
1.6% |
| Panniculitis |
1.6% |
| Pneumonitis |
1.6% |
| Renal Failure |
1.6% |
|
| Secondary |
| Malignant Melanoma |
58.2% |
| Prophylaxis |
6.0% |
| Diabetes Mellitus |
4.2% |
| Hypertension |
3.6% |
| Pyrexia |
3.0% |
| Metastatic Malignant Melanoma |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Cough |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Facial Nerve Disorder |
2.1% |
| Hypokalaemia |
1.8% |
| Nausea |
1.8% |
| Epilepsy |
1.5% |
| Febrile Neutropenia |
1.5% |
| Depression |
1.2% |
| Medical Diet |
1.2% |
| Wheezing |
1.2% |
| Back Pain |
0.9% |
| Brain Oedema |
0.9% |
| Dehydration |
0.9% |
|
| Pyrexia |
54.5% |
| Vomiting |
5.7% |
| Chorioretinopathy |
4.5% |
| Ejection Fraction Decreased |
4.5% |
| Basal Cell Carcinoma |
3.4% |
| Hepatic Enzyme Increased |
3.4% |
| Alanine Aminotransferase Increased |
2.3% |
| Confusional State |
2.3% |
| Hyponatraemia |
2.3% |
| Sepsis |
2.3% |
| Squamous Cell Carcinoma |
2.3% |
| Squamous Cell Carcinoma Of Skin |
2.3% |
| Urinary Tract Infection |
2.3% |
| Atrial Fibrillation |
1.1% |
| Febrile Neutropenia |
1.1% |
| Hepatotoxicity |
1.1% |
| Hypercreatinaemia |
1.1% |
| Hyperglycaemia |
1.1% |
| Malignant Melanoma In Situ |
1.1% |
| Myocardial Infarction |
1.1% |
|
| Concomitant |
| Colorectal Cancer |
38.5% |
| Convulsion |
7.7% |
| Hyperglycaemia |
7.7% |
| Hypokalaemia |
7.7% |
| Malignant Melanoma |
7.7% |
| Metastatic Malignant Melanoma |
7.7% |
| Peptic Ulcer |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Restless Legs Syndrome |
7.7% |
|
| Death |
20.0% |
| Hypokalaemia |
20.0% |
| Metastases To Central Nervous System |
20.0% |
| Pyrexia |
20.0% |
| Vomiting |
20.0% |
|
